News

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the European Commission has purchased an additional 150 million doses of Moderna’s COVID-19 vaccine, including the ability to purchase other COVID-19 vaccine candidates from Moderna’s...

Tonix Pharmaceuticals has announced its intention to develop the investigational candidate TNX-102 for the potential treatment of long COVID syndrome – also known as Post-Acute Sequelae of COVID-19 (PASC). Currently, TNX-102 SL (cyclobenzaprine HCl sublingual tablets) is in mid-phase 3...

Fujitsu Japan Limited announced that it will initiate a new research project with a research team led by Takefumi Yamashita, Project Associate Professor of Research Center for Advanced Science and Technology (RCAST) , the University of Tokyo utilizing the...

The COVID-19 pandemic has stopped most businesses with the strict guideline of social distancing and staying at home, thus many have lost their livelihood. Those companies that are still open are now left with the responsibility to protect their...

Coriolis Pharma, a provider of research and development of for (bio)pharmaceutical drugs, is expanding its advanced therapy medicinal products (ATMP) development facilities under biosafety level S2 (BSL2 / S2). Re-construction of an existing building near the Coriolis headquarters started in...

Vectura Group plc, an inhalation CDMO, has signed an agreement with Incannex Healthcare Ltd., an Australian cannabinoid medicines development company, to provide preclinical development services for IHL-216A, Incannex’s proprietary inhaled drug product for the treatment of traumatic brain injury...

Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against COVID-19 but also other coronaviruses and triggered the immune system to fight off a dangerous...